NCPC New Drug Research & Development Co. Ltd., a subsidiary of Province of Hebei, is a Chinese company located in Shijiazhuang. The firm manufactures and distributes medicines.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Knoll AG, part of BASF SE, is a company headquartered in Haren, Germany, that develops pharmaceuticals.

Heumann PCS GmbH, a subsidiary of Fareva SA, is a company headquartered in Feucht, Germany, that specializes in contract manufacturing services for the pharmaceutical industry. It was acquired by Fareva SA from Pfizer Inc. on December 31, 2007.

Medichem SA is a Spanish company located in Sant Joan Despi with domestic subsidiaries. The firm manufactures and supplies pharmaceutical ingredients. It was founded in 1972. José Luis Rodríguez has been the CEO since 1996.

Founded in 2002, Hefei Lifang Pharmaceutical Co., Ltd. is an innovative pharmaceutical enterprise integrating the research and development, production and sales of pharmaceutical preparations and raw materials, and the wholesale and retail of pharmaceuticals and medical devices. It has formed a whole industry for the pharmaceutical industry and pharmaceutical business. Chain coverage, the main industrial products involve cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs, and other fields. Lifang Pharmaceutical owns 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 pharmaceutical retail chain enterprise, and has been successfully listed on the SME board of the Shenzhen Stock Exchange on December 15, 2020.

Knorr-Bremse GmbH manufactures braking systems and sub-systems for rail and commercial vehicles. It offers magnetic track and eddy current breaks, flange devices, windscreen wiper and washing systems, sanding systems, and brake test units. The company was founded by Georg Knorr in 1905 and is headquartered in Mödling, Austria.

Chemische Fabrik Berg GmbH, a subsidiary of PMC Global, Inc., is a German company located in Bitterfeld-Wolfen that manufactures and distributes pharmaceutical ingredients. Michael Grosse is the current CEO of the firm.

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through the following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants. The Human Medicine division manufactures and supplies pharmaceuticals, pharmaceutical raw materials and functional health products. The company was founded on December 28, 1995 and is headquartered in Hwaseong-si, South Korea.

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. is a company headquartered in Beijing, China, focused on commercial physical and biological research.

Hefei Huafang Pharmaceutical Technology Co., Ltd., established on 2003-12-01, Business scope includes drug research and development,Pharmaceutical new technology,New technology research design and transfer;food,cosmetic,Chemicals,Technical design of chemical products,consult,introduce,analysis test;pharmaceutical production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kangmei Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical, health care and health food products. It offers Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others, as well as chemical drugs, including Clarithromycin Dispersible Tablets, Doxazosin Mesylate Tablets, Propiverine Hydrochloride Tablets and paracetamol and pseudoephedrine hydrochloride tablets, among others. The company also provides property management services. Kangmei Pharmaceutical was founded on June 9, 1997 and is headquartered in Shenzhen, China.

Eurofarma is the first Brazilian multinational pharmaceutical company, founded in 1972, present in Latin America. It operates in all major pharmaceutical segments, occupying the 2nd position in the most prescribed laboratories ranking by the Brazilian medical community and is among the Top 4 generic drug laboratories in the country. Holder of a broad range of products, it also holds licenses and strategic partnerships for the promotion and marketing of third party’s products. The company's sales added up to around US$ 1 billion in 2014, reaching a 20% growth over the previous year. Licenses accounted for 10% of the total, approximately. Eurofarma has the largest medical sales force in Brazil (about 2,000 representatives) and is considered one of the best companies to work for, according to key publications. The company keeps its own operations in 15 countries, has over 10 manufacturing plants strategically located and an ambitious internationalization plan with growing investment in the R&D area.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Excella GmbH has been serving the pharmaceutical industry for more than 35 years with high quality API‘s and finished dosage forms. Recent investments have directed our focus towards high containment products (including OEB5) and a one-stop-shopping approach. Excella supplies products to the generic industry but although manufactures for big pharma life cycle end products and develops processes for innovative API‘s and novel solid dosage forms. Services offered range from early product development through registration support to state-of-the-art manufacturing. Excella‘s Feucht site has an excellent track record with the FDA and other regulatory agencies since 1983 and is Safebridge certified.

Zhejiang Shangyao Jiuxu Pharmaceutical Co., Ltd, established on 2003-03-27, The scope of business includes large-volume injections,Pills,soft capsule,tablet,hard capsule,Granules,API(Sodium Bisulfite Andrographolide,Ibutilide fumarate,Propofol,etomidate,Pazufloxacin,doxapram,Decitabine,Midazolam,repaglinide,Clevidipine Butyrate,Cyclovirid buxillusD,Edaravone),Powder,API(Pantoprazole Sodium)production;Production and sales of food;metal crafts,Arts and crafts processing(Dangerous goods and special approval are excluded and cultural relics are not included)medicine,skin care products,food research;Investment Advisory(The above scope except financial,securities,futures,Business consulting such as certification and accreditation);Research on pharmaceutical intermediates,technology development;baby products,sales of chemical products(Removal of hazardous chemicals,Precursor chemicals and monitored chemicals);General commodity information consultation(Without the approval of financial and other regulatory authorities, it is not allowed to engage in financing deposits from the public,financing guarantee,Financial services such as wealth management on behalf of customers).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shaanxi Yazhuo Zhishang Enterprise Management Consulting Co., Ltd., established on 2017-07-31, Business scope includes general items:HR Services(Excludes job brokerage activities,Labor dispatch service);Business Management Consulting;marketing planning;Corporate Image Planning;Conference and Exhibition Services;market survey(Does not include foreign investigations);Labor service(Does not include labor dispatch);Advertising Design,acting;advertising;advertisement making;Data processing and storage support services;Retailing of computer software, hardware and auxiliary equipment;Information Technology Consulting Services;Internet of Things Technology Services;brand management;Business agency service;tax service;Financial Advisory;Legal advice(Does not include business that requires a law firm to practice license according to law);Corporate Headquarters Management;Engineering Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:career brokerage.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)